Article
Novel P2 tris-tetrahydrofuran group in antiviral compound 1 (GRL-0519) fills the S2 binding pocket of selected mutants of HIV-1 protease.
Journal of medicinal chemistry - 14 Feb 2013
Zhang Hongmei, Wang Yuan-Fang, Shen Chen-Hsiang, Agniswamy Johnson, Rao Kalapala Venkateswara, Xu Chun-Xiao, Ghosh Arun K, Harrison Robert W, Weber Irene T
Abstract excerpt
GRL-0519 (1) is a potent antiviral inhibitor of HIV-1 protease (PR) possessing tris-tetrahydrofuran (tris-THF) at P2. The high resolution X-ray crystal structures of inhibitor 1 in complexes with single substitution mutants PR(R8Q), PR(D30N), PR(I50V), PR(I54M), and PR(V82A) were analyzed in relation to kinetic data. The smaller valine side chain in PR(I50V) eliminated hydrophobic interactions with inhibitor and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
